| Pharmaceutical active ingredients: |
| Methylprednisolone |
| Available forms, composition and doses of Nirypan: |
| N / A |
| Nirypan medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsOestrogens and progesterones and related synthetic drugsTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AA01 - MethylprednisoloneD10AA02 - MethylprednisoloneH02AB04 - Methylprednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nipodal | Prochlorperazine | Unidentified Pharmaceutical Company |
| Nipsan | Diazinon | Unidentified Pharmaceutical Company |
| Niquetamida | Nikethamide | Unidentified Pharmaceutical Company |
| Nirazin | Nicarbazin | Unidentified Pharmaceutical Company |
| Nirvonal | Phenobarbital | Unidentified Pharmaceutical Company |
| Nisetamide | Nikethamide | Unidentified Pharmaceutical Company |
| Nisidana | Opipramol | Unidentified Pharmaceutical Company |
| Nisocor | Nisoldipine | Unidentified Pharmaceutical Company |
| Nisona | Prednisone | Unidentified Pharmaceutical Company |
| Nisotin | Ethionamide | Unidentified Pharmaceutical Company |